Graham Capital Management, L.P. Procept Bio Robotics Corp Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Graham Capital Management, L.P. holds 3,779 shares of PRCT stock, worth $129,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,779
Previous 36,234
89.57%
Holding current value
$129,922
Previous $2.11 Million
89.72%
% of portfolio
0.0%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$180 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$120 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.2 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$53.9 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$52.5 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.53B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...